204 related articles for article (PubMed ID: 28672324)
1. High Generic Drug Prices and Market Competition: A Retrospective Cohort Study.
Dave CV; Kesselheim AS; Fox ER; Qiu P; Hartzema A
Ann Intern Med; 2017 Aug; 167(3):145-151. PubMed ID: 28672324
[TBL] [Abstract][Full Text] [Related]
2. Predictors of Drug Shortages and Association with Generic Drug Prices: A Retrospective Cohort Study.
Dave CV; Pawar A; Fox ER; Brill G; Kesselheim AS
Value Health; 2018 Nov; 21(11):1286-1290. PubMed ID: 30442275
[TBL] [Abstract][Full Text] [Related]
3. Association Between Market Competition and Prices of Generic Topical Dermatology Drugs.
Li DG; Joyce C; Mostaghimi A
JAMA Dermatol; 2018 Dec; 154(12):1441-1446. PubMed ID: 30383117
[TBL] [Abstract][Full Text] [Related]
4. Long-term Medicaid excess payments from alleged price manipulation of generic lorazepam.
Bian B; Gorevski E; Kelton CM; Guo JJ; Martin Boone JE
J Manag Care Pharm; 2012 Sep; 18(7):506-15. PubMed ID: 22971204
[TBL] [Abstract][Full Text] [Related]
5. The Evolution of Supply and Demand in Markets for Generic Drugs.
Frank RG; McGuire TG; Nason I
Milbank Q; 2021 Sep; 99(3):828-852. PubMed ID: 34075623
[TBL] [Abstract][Full Text] [Related]
6. Trends and determinants of retail prescription drug costs.
Teasdale B; Nguyen A; van Meijgaard J; Schulman KA
Health Serv Res; 2022 Jun; 57(3):548-556. PubMed ID: 35211965
[TBL] [Abstract][Full Text] [Related]
7. The High Cost of Prescription Drugs in the United States: Origins and Prospects for Reform.
Kesselheim AS; Avorn J; Sarpatwari A
JAMA; 2016 Aug 23-30; 316(8):858-71. PubMed ID: 27552619
[TBL] [Abstract][Full Text] [Related]
8. Association of Generic Competition With Price Decreases in Physician-Administered Drugs and Estimated Price Decreases for Biosimilar Competition.
Dickson SR; Kent T
JAMA Netw Open; 2021 Nov; 4(11):e2133451. PubMed ID: 34779844
[TBL] [Abstract][Full Text] [Related]
9. Physician practice competition and prices paid by private insurers for office visits.
Baker LC; Bundorf MK; Royalty AB; Levin Z
JAMA; 2014 Oct 22-29; 312(16):1653-62. PubMed ID: 25335147
[TBL] [Abstract][Full Text] [Related]
10. Decreasing utilization and increasing prices of brand-name oral contraceptive pills: Implications to societal costs and market competition.
Zhang JX
PLoS One; 2020; 15(6):e0234463. PubMed ID: 32525965
[TBL] [Abstract][Full Text] [Related]
11. Effect of Competition on Generic Drug Prices.
Nguyen NX; Sheingold SH; Tarazi W; Bosworth A
Appl Health Econ Health Policy; 2022 Mar; 20(2):243-253. PubMed ID: 34904207
[TBL] [Abstract][Full Text] [Related]
12. OSTEOPOROSIS DRUGS MARKETED IN THE UNITED STATES: GENERIC COMPETITION, PRICING STRUCTURE, AND DISPERSION AMONG PAYERS.
Balkhi B; Seoane-Vazquez E; Rodriguez-Monguio R
Int J Technol Assess Health Care; 2016 Jan; 32(6):385-392. PubMed ID: 28065194
[TBL] [Abstract][Full Text] [Related]
13. Are drug prices subject to creative destruction? Evidence from the US, 1997-2017.
Lichtenberg FR
Health Econ; 2021 Aug; 30(8):1910-1932. PubMed ID: 33987916
[TBL] [Abstract][Full Text] [Related]
14. Generic Drugs in the United States: Policies to Address Pricing and Competition.
Gupta R; Shah ND; Ross JS
Clin Pharmacol Ther; 2019 Feb; 105(2):329-337. PubMed ID: 30471089
[TBL] [Abstract][Full Text] [Related]
15. The effect of generic competition on the price of brand-name drugs.
Lexchin J
Health Policy; 2004 Apr; 68(1):47-54. PubMed ID: 15033552
[TBL] [Abstract][Full Text] [Related]
16. Product-line extensions and pricing strategies of brand-name drugs facing patent expiration.
Hong SH; Shepherd MD; Scoones D; Wan TT
J Manag Care Pharm; 2005; 11(9):746-54. PubMed ID: 16300418
[TBL] [Abstract][Full Text] [Related]
17. Does the market share of generic medicines influence the price level?: a European analysis.
Dylst P; Simoens S
Pharmacoeconomics; 2011 Oct; 29(10):875-82. PubMed ID: 21797288
[TBL] [Abstract][Full Text] [Related]
18. Trends in Pricing and Generic Competition Within the Oral Antibiotic Drug Market in the United States.
Alpern JD; Zhang L; Stauffer WM; Kesselheim AS
Clin Infect Dis; 2017 Nov; 65(11):1848-1852. PubMed ID: 29020146
[TBL] [Abstract][Full Text] [Related]
19. What do pharmaceuticals really cost in the long run?
Lakdawalla D; MacEwan JP; Dubois R; Westrich K; Berdud M; Towse A
Am J Manag Care; 2017 Aug; 23(8):488-493. PubMed ID: 29087143
[TBL] [Abstract][Full Text] [Related]
20. Determinants of Market Exclusivity for Prescription Drugs in the United States.
Kesselheim AS; Sinha MS; Avorn J
JAMA Intern Med; 2017 Nov; 177(11):1658-1664. PubMed ID: 28892528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]